161 related articles for article (PubMed ID: 8758473)
21. In vitro activity of fluoroquinolones, azithromycin and doxycycline against chlamydia trachomatis cultured from men with chronic lower urinary tract symptoms.
Smelov V; Perekalina T; Gorelov A; Smelova N; Artemenko N; Norman L
Eur Urol; 2004 Nov; 46(5):647-50. PubMed ID: 15474277
[TBL] [Abstract][Full Text] [Related]
22. Association of the in vitro susceptibility of clinical isolates of chlamydia trachomatis with serovar and duration of antibiotic exposure.
Zheng H; Xue Y; Bai S; Qin X; Lu P; Yang B
Sex Transm Dis; 2015 Mar; 42(3):115-9. PubMed ID: 25668641
[TBL] [Abstract][Full Text] [Related]
23. In vitro susceptibility of recent clinical isolates of Chlamydia trachomatis to macrolides and tetracyclines.
Samra Z; Rosenberg S; Soffer Y; Dan M
Diagn Microbiol Infect Dis; 2001 Mar; 39(3):177-9. PubMed ID: 11337185
[TBL] [Abstract][Full Text] [Related]
24. In-vitro activity of azithromycin against Chlamydia trachomatis.
Scieux C; Bianchi A; Chappey B; Vassias I; Pérol Y
J Antimicrob Chemother; 1990 Jan; 25 Suppl A():7-10. PubMed ID: 2154440
[TBL] [Abstract][Full Text] [Related]
25. In-vitro activity of roxithromycin against Chlamydia trachomatis.
Moroni A; Sambri V; Rumpianesi F; Donati M; Cevenini R
J Chemother; 1991 Jan; 3 Suppl 1():28-9. PubMed ID: 12041779
[TBL] [Abstract][Full Text] [Related]
26. [Minimum inhibitory concentration and minimum bactericidal concentration of tetracycline and erythromycin in 35 recent Munich isolates of Chlamydia trachomatis].
Korting HC; Hartinger A
Hautarzt; 1988 Mar; 39(3):161-5. PubMed ID: 3378887
[TBL] [Abstract][Full Text] [Related]
27. [In vitro effectiveness of ofloxacin and ciprofloxacin in genital Chlamydia trachomatis isolates measured by minimal inhibitory concentration and minimal bactericidal concentration].
Hartinger A; Korting HC; Neubert U; Blaufuss H
Z Hautkr; 1988 Jan; 63(1):29-32. PubMed ID: 3162627
[TBL] [Abstract][Full Text] [Related]
28. Potential of a novel polyherbal formulation BASANT for prevention of Chlamydia trachomatis infection.
Bhengraj AR; Dar SA; Talwar GP; Mittal A
Int J Antimicrob Agents; 2008 Jul; 32(1):84-8. PubMed ID: 18524545
[TBL] [Abstract][Full Text] [Related]
29. In vitro activities of tetracycline & ciprofloxacin against Chlamydia trachomatis isolates from conjunctivitis patients.
Madhavan HN; Roy S; Malathy J
Indian J Med Res; 1996 Mar; 103():138-41. PubMed ID: 9062038
[TBL] [Abstract][Full Text] [Related]
30. In-vitro activity of gatifloxacin against Chlamydia trachomatis and Chlamydia pneumoniae.
Roblin PM; Hammerschlag MR
J Antimicrob Chemother; 1999 Oct; 44(4):549-51. PubMed ID: 10588319
[TBL] [Abstract][Full Text] [Related]
31. [Comparative in vitro activity of a new macrolide RU 28965 and of erythromycin against Chlamydia trachomatis].
Dutilh B; de Barbeyrac B; Lafferrière C; Bébéar C
Pathol Biol (Paris); 1986 May; 34(5):445-7. PubMed ID: 3534718
[TBL] [Abstract][Full Text] [Related]
32. In vitro activities of ofloxacin and four other new quinoline-carboxylic acids against Chlamydia trachomatis.
Nagayama A; Nakao T; Taen H
Antimicrob Agents Chemother; 1988 Nov; 32(11):1735-7. PubMed ID: 3150916
[TBL] [Abstract][Full Text] [Related]
33. In vitro susceptibility of 7.5-kb common plasmid-free Chlamydia trachomatis strains.
Miyashita N; Matsumoto A; Matsushima T
Microbiol Immunol; 2000; 44(4):267-9. PubMed ID: 10832970
[TBL] [Abstract][Full Text] [Related]
34. Chlamydia trachomatis: in vitro susceptibility of genital and ocular isolates to some quinolones, amoxicillin and azithromycin.
Børsum T; Dannevig L; Størvold G; Melby K
Chemotherapy; 1990; 36(6):407-15. PubMed ID: 1963393
[TBL] [Abstract][Full Text] [Related]
35. In vitro activity of antibiotics against Ureaplasma urealyticum and Chlamydia trachomatis strains from patients with nongonococcal urethritis.
Busolo F; Conventi L
Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):407-10. PubMed ID: 3137045
[TBL] [Abstract][Full Text] [Related]
36. Chlamydia trachomatis antimicrobial susceptibility in colorectal and endocervical cells.
Foschi C; Salvo M; Cevenini R; Marangoni A
J Antimicrob Chemother; 2018 Feb; 73(2):409-413. PubMed ID: 29077843
[TBL] [Abstract][Full Text] [Related]
37. In vitro activity of dirithromycin against Chlamydia trachomatis.
Segreti J; Kapell KS
Antimicrob Agents Chemother; 1994 Sep; 38(9):2213-4. PubMed ID: 7811051
[TBL] [Abstract][Full Text] [Related]
38. Phenotypic antimicrobial susceptibility testing of Chlamydia trachomatis isolates from patients with persistent or successfully treated infections.
Pitt R; Alexander S; Ison C; Horner P; Hathorn E; Goold P; Woodford N; Cole MJ
J Antimicrob Chemother; 2018 Mar; 73(3):680-686. PubMed ID: 29207004
[TBL] [Abstract][Full Text] [Related]
39. Chlamydia trachomatis survival in the presence of two fluoroquinolones (lomefloxacin versus levofloxacin) in patients with chronic prostatitis syndrome.
Smelov V; Perekalina T; Artemenko N; Smelova N; Ukleeva G; Gorelov A
Andrologia; 2005 Jun; 37(2-3):61-4. PubMed ID: 16026425
[TBL] [Abstract][Full Text] [Related]
40. Susceptibility of Chlamydia trachomatis to trovafloxacin.
Jones RB; Van der Pol B; Johnson RB
J Antimicrob Chemother; 1997 Jun; 39 Suppl B():63-5. PubMed ID: 9222072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
